Resources

In the third part of our series on Industrial Strategy, Lewis Miles and Maddie Cass provide a deep dive into the Digital and Technologies Sector Plan, analysing how these policies aim to foster growth in the UK's life sciences and engineering biology sectors. We also look forward to strengthening relations and gaining key insight from our US sister organisation with BIO's upcoming UK visit.

In the third instalment of our updates on new Government policy, Lewis Miles and Maddie Cass from BIA’s Policy and Public Affairs team take a deep dive into the Industrial Strategy and the Digital and Technologies Sector Plan, breaking down the implications for engineering biology and the wider life sciences sector.  

In the second instalment of our blog series on new government policy, Lewis Miles and Linda Bedenik examine the UK's Trade and National Security strategies and what they mean for biotech.

In a shifting global landscape, we break down how the UK's new Trade and National Security strategies aim to future-proof our biotech sector.

In this blog, Martin Turner, Director of Policy and External Affairs at BIA, reflects on the long-anticipated Life Sciences Sector Plan and what it means for scaling UK biotech. This is the first in a series of blogs that will be released in the coming weeks.

In my final summer update as BIA CEO, I reflect on 12 amazing years and look ahead to my new role as Executive Chair of the Office for Life Sciences. This week we’ve also published our latest finance report, and we’re hiring - so if you’re looking for your next challenge, now’s the time to join Team BIA.

In this blog, Dr Jonathan Tobin, Partner, Brandon Capital, explores how the UK pension industry can unlock greater economic and societal value by following Australia's example.

After 13 years at the helm of our Association, Steve Bates has tendered his resignation as CEO of the BIA. His last day at the BIA will be Friday, 26 September 2025. We all wish him well in his new role and know he will continue to champion our sector at home and abroad. 

A response from Discovery Park’s CEO, Mayer Schreiber, in light of the Government’s Life Science Sector Plan.

In this article, Kate Barclay, Skills Strategy Consultant at BIA, outlines new changes to UK immigration law and how they will impact the life sciences sector. Prepared in collaboration with legal experts at Eversheds-Sutherland LLP.

NHS 10 Year Health Plan for England, a strategy for European Life Sciences and hope to see you at the “sunny” BIA Summer Party on Wednesday.

OK, I admit defeat. The UK government has published 3.5 key strategies that affect our sector in a week and I’m expecting at least two more in the coming days – a full analysis of so much text by today is beyond me but…

BIA welcomed the focus on life sciences SMEs, engineering biology, and the measures designed to help high-growth companies scale and remain rooted in the UK.

A major funding boost, support for scale-ups, and regulatory reform—this week’s update explores how the Government’s new Industrial Strategy backs our sector. Plus, Draig Therapeutics launches with $140 million, the UK shines at BIO in Boston, and Syncona sets its sights on future growth.

UK life sciences take centre stage at BIO following a promising Spending Review.

From a multi-billion-pound boost to R&D and life sciences manufacturing, to scaling innovative businesses through the British Business Bank, the Review signals significant investment.

Steve Bates OBE, CEO of the UK BioIndustry Association, responded to the government's Spending Review.

Chancellor Rachel Reeves will announce a transformative £86 billion in the Spending Review to turbo-charge our fastest growing sectors, from tech and life sciences, to advanced manufacturing and defence, as part of the government’s plan to invest in Britain’s renewal through our Modern Industrial Strategy.

Positive news ahead of Spending Review (join our webinar this Friday), latest on getting pensions investment into UK life sciences and more!